| X0302917 | 注射用重组抗HER2人源化单克隆抗体 | Recombinant humanized monoclonal antibody against HER2 | Lyophilized | Biological Products(2) | New Drug Application | 2004-04-02 | 上海中信国健药业有限公司 | Sunshine Guojian Pharmaceutical(Shanghai) Co Ltd | Certificate Issued | 2004-07-12 | view |
| CXSS0700053 | 注射用重组抗HER2人源化单克隆抗体 | Recombinant humanized monoclonal antibody against HER2 | Lyophilized | Biological Products(2) | New Drug Application | 2007-08-22 | 上海中信国健药业有限公司 | Sunshine Guojian Pharmaceutical(Shanghai) Co Ltd | Certificate Issued | 2008-10-29 | view |
| CXSL1000002 | 注射用重组抗HER2人源化单克隆抗体 | Recombinant humanized monoclonal antibody against HER2 | Lyophilized | Biological Products(2) | New Drug Application | 2010-03-25 | 哈药集团生物工程有限公司 | Harbin Pharmaceutical Group Bioengineering Co Ltd | Certificate Issued | 2011-08-03 | view |
| CXSR1100006 | 注射用重组抗HER2人源化单克隆抗体 | Recombinant humanized monoclonal antibody against HER2 | Lyophilized | Biological Products | State Standards | 2011-09-27 | 哈药集团生物工程有限公司 | Harbin Pharmaceutical Group Bioengineering Co Ltd | Certificate Issued | 2012-07-03 | view |
| CXSL1100032 | 注射用重组抗HER2人源化单克隆抗体 | Recombinant humanized monoclonal antibody against HER2 | Lyophilized | Biological Products(2) | New Drug Application | 2011-08-26 | 嘉和生物药业有限公司 | Genor Biopharma Co Ltd | Certificate Issued | 2013-07-19 | view |
| CXSL1100036 | 注射用重组抗HER2人源化单克隆抗体 | Recombinant humanized monoclonal antibody against HER2 | Lyophilized | Biological Products(2) | New Drug Application | 2011-07-21 | 齐鲁制药有限公司 | QILU Pharmaceutical Co Ltd | Certificate Issued | 2013-07-19 | view |
| CXSL1200048 | 注射用重组抗HER2人源化单克隆抗体 | Recombinant humanized monoclonal antibody against HER2 | Lyophilized | Biological Products(2) | New Drug Application | 2012-11-08 | 上海中信国健药业股份有限公司 | Sunshine Guojian Pharmaceutical(Shanghai) Co Ltd | Certificate Issued | 2014-06-05 | view |
| CXSL1200099 | 注射用重组抗HER2人源化单克隆抗体 | Recombinant humanized monoclonal antibody against HER2 | Lyophilized | Biological Products(2) | New Drug Application | 2013-04-28 | 上海复宏汉霖生物技术有限公司 | Shanghai Henlius Biotech Co Ltd | Certificate Issued | 2015-07-13 | view |
| CXSL1400065 | 注射用重组抗HER2人源化单克隆抗体 | Recombinant humanized monoclonal antibody against HER2 | Lyophilized | Biological Products(2) | New Drug Application | 2014-07-23 | 上海复宏汉霖生物技术有限公司 | Shanghai Henlius Biotech Co Ltd | Certificate Issued | 2016-01-29 | view |
| CXSL1400053 | 注射用重组抗HER2人源化单克隆抗体 | Recombinant humanized monoclonal antibody against HER2 | Lyophilized | Biological Products(2) | New Drug Application | 2014-07-14 | 深圳万乐药业有限公司 | Shenzhen Main Luck Pharmaceuticals INC | Certificate Issued | 2016-02-18 | view |
| CXSL1400092 | 注射用重组抗HER2人源化单克隆抗体 | Recombinant humanized monoclonal antibody against HER2 | Lyophilized | Biological Products(2) | New Drug Application | 2014-11-25 | 浙江海正药业股份有限公司 | Zhejiang Hisun Pharmaceutical Co Ltd | Certificate Issued | 2016-02-19 | view |
| CXSS1100005 | 注射用重组抗HER2人源化单克隆抗体 | Recombinant humanized monoclonal antibody against HER2 | Lyophilized | Biological Products(2) | New Drug Application | 2011-07-18 | 上海中信国健药业股份有限公司 | Sunshine Guojian Pharmaceutical(Shanghai) Co Ltd | Certificate Issued | 2016-08-01 | view |
| CXSL1700058 | 注射用重组抗HER2人源化单抗-DM1偶联物 | recombinant humanized anti-HER2 mAb-DM1 | Lyophilized | Biological Products(2) | New Drug Application | 2017-08-24 | 三生国健药业（上海）股份有限公司 | Sunshine Guojian Pharmaceutical(Shanghai) Co Ltd | In Review | 2017-08-22 | view |
| CXSL1600070 | 注射用重组抗HER2人源化单克隆抗体组合物 | B-002 | Lyophilized | Biological Products(1) | New Drug Application | 2017-02-13 | 上海医药集团股份有限公司 | Shanghai Pharmaceuticals Holding Co Ltd | Certificate Issued | 2017-09-27 | view |
| CXSL1600103 | 注射用重组抗HER2人源化单克隆抗体-DM1 | recombinant humanized anti-HER2 mAb-DM1 | Lyophilized | Biological Products(1) | New Drug Application | 2017-01-05 | 齐鲁制药有限公司 | QILU Pharmaceutical Co Ltd | Certificate Issued | 2017-09-27 | view |
| CXSL1700072 | 注射用重组抗HER2人源化单克隆抗体-MCC-DM1偶联剂 | B-003 | Lyophilized | Biological Products(2) | New Drug Application | 2017-07-31 | 上海交联药物研发有限公司 | Shanghai Shangyao Cross Linked Pharmaceutical Technology Co Ltd | Certificate Issued | 2018-02-25 | view |
| CXSL1700022 | 注射用重组抗HER2人源化单克隆抗体偶联美登素衍生物DM1 | HS-630 | Lyophilized | Biological Products(2) | New Drug Application | 2017-05-25 | 浙江海正药业股份有限公司 | Zhejiang Hisun Pharmaceutical Co Ltd | Certificate Issued | 2018-05-08 | view |
| CXSL1800072 | 注射用重组抗HER2人源化单克隆抗体 | Recombinant humanized monoclonal antibody against HER2 | Lyophilized | Biological Products(2) | New Drug Application | 2018-06-29 | 齐鲁制药有限公司 | QILU Pharmaceutical Co Ltd | In Review | 2018-06-28 | view |
| CXSL1700045 | 注射用重组抗her2人源化单克隆抗体 | Recombinant humanized monoclonal antibody against HER2 | Lyophilized | Biological Products(2) | New Drug Application | 2017-08-15 | 上海生物制品研究所有限责任公司 | Shanghai Institute of Biological Products Co Ltd | Certificate Issued | 2018-08-13 | view |
| CXSL1900083 | 注射用重组人源化抗HER2单克隆抗体 | Recombinant humanized monoclonal antibody against HER2 | Lyophilized | Biological Products(2) | New Drug Application | 2019-08-06 | 喜康（武汉）生物医药有限公司 | Xikang(Wuhan)Biopharmaceutical Co Ltd | In Review | 2019-08-05 | view |
